Uab Clinical Trials Cancer Download Free
2021年5月11日Download here: http://gg.gg/ukh8i
*Uab Clinical Trials Cancer download free. full
*Uab Clinical Trials Cancer Download Free Version
*UAB Medicine is changing the world of healthcare. As a leading academic medical center and Alabama’s largest employer, UAB is a national leader in patient care, research, and training. Medical professionals from around the nation look to us to be in the vanguard of medicine, and we deliver on that expectation. email protected.
*The motto of the UAB Phase 1 Clinical Trials Program is ’ ”. It is dedicated to provide HOPE to cancer patients options and compassionate care. It is our hope that patients with cancer, for whom conventional therapeutic options no longer provide benefits, will come to see the Phase 1.
*There are now four single-institution published randomized trials comparing LDR to HDR brachytherapy,. Our objective of this report is to evaluate clinical outcome of cervical cancer patients treated at the University of Alabama at Birmingham (UAB) with either LDR or HDR brachytherapy within the same period of time.We responded agressively to COVID-19 when it struck.
UAB Department of Genetics Clinical Programs Prenatal Pediatric Adult Cancer Specialty Clinics Clinical Lab Cytogenetics Medical Genomics Biochemical Genetics Research Cancer Genetics Systems Biology Bioinformatics Animal Models Clinical Trials Developmental Biology Core Labs Transgenic/Animal Models Genomics Education Graduate Undergraduate.We’re making an impact on the COVID-19 crisis through research, testing, guidance, and community care. Our leadership and infectious disease experts have been working around the clock to ensure the most effective plans are executed to guide our enterprise, the Birmingham community, and the State of Alabama. Our mission is to partner with stakeholders and influencers to ensure the health and safety of all Alabamians.We went to work in all areas of our mission.
*
UAB is committed to decreasing racial and socioeconomic disparities for health and health care. The COVID-19 pandemic has exposed the deadly consequences of health disparities, and our leaders recognize the importance of informing the public about health disparities and developing effective strategies to combat them.
*Community-based COVID-19 testing sites in underserved areas launched April 30. The sites employ a mobile, drive-through, and walk-up testing model, and are currently serving many minority communities who may have transportation or health care barriers. Testing has been offered at locations across Jefferson County. Culturally-sensitive Patient Navigators guide individuals through pre-screening, testing, and test results.
*Mobile community testing is possible due to UAB’s partnerships with the Jefferson County Department of Health, UAB Medicine, Live HealthSmart Alabama, and the Minority Health & Health Disparities Research Center.
*COVID-19 education is being disseminated at each site, and across Jefferson County to help stop the spread of the virus.
*
UAB clinicians and researchers work around the clock to make testing available for as many people as possible.
*Sentinel testing is voluntary for staff and faculty, and individuals are selected at random to participate. Multiple other options for testing are available to UAB employees.
*All students on campus are required to get tested. Read more here.
*The GuideSafe™ Exposure Notification App tracks symptoms of individuals and directs them to a testing site based on their employment and/or student status.
*
UAB continues to be a leader in fighting the COVID-19 crisis with clinical trials and research.
*On May 1, 14 basic science projects were selected for funding due to their high-impact probability on COVID-19. Read more here.
*On Aug. 1, a second round of research initiatives began, focusing on high-impact studies related to COVID-19—from vaccines and therapeutics to antibodies, disparity risk, cytokine syndrome, and much more. Out of the 10 pilot projects, all principal investigators or co-investigators were selected from the School of Medicine, and one investigator was selected from the School of Public Health in the Department of Epidemiology.
*UAB is a participant in the NIH-sponsored global clinical trial to evaluate the safety and efficacy of the novel therapeutic drug, remdesivir. UAB is also conducting a first-in-U.S. study that is testing a treatment to halt the potentially fatal immune overreaction known as cytokine storm syndrome in COVID-19 patients. Last, expanded access protocol for use of COVID-19 convalescent plasma was activated onsite at UAB in spring 2020 organized through the NIH/NCATS’s Trial Innovation Network.
*Browse research articles related to COVID-19 from UAB News.
*
As the 2020-2021 academic year began, the School of Medicine found ways to continue to meet our mission of training the next generation of leaders in medicine while safeguarding the health and safety of our students and trainees. Under the direction of Craig Hoesley, M.D., senior associate dean for Medical Education, program leaders continue to follow guidance shared by the AAMC and communicate regularly with each class to ensure they have the latest information possible.
Medical students looking for updates can visit the COVID-19 Updates and FAQs page on the School of Medicine website.
*Many preclinical courses moved to virtual learning, while clinical coursework continues with enhanced health check protocols to ensure the safety of our students and the patients they encounter.
*Medical students have found numerous ways to contribute their time and service to those in need during the pandemic. Many have volunteered for organizations that are providing a variety of services to the community, including Bham Strong, Christ Health Center, and the UAB COVID-19 call center, among others. Read more about their contributions from SOM News.
*While annual events like Match Day, Commencement, and the White Coat Welcome celebration were modified and moved to an online format, care was taken to ensure that these milestone events were still meaningful and memorable for our students. (A full White Coat Ceremony will be held for the 2020 entering class at the beginning of their third year of medical school.)
*Read more about how the School of Medicine’s medical education programs are reacting and adapting to the challenges of the COVID-19 pandemic in the news stories below.
*
We are honored that millions of patients each year trust UAB Medicine with their care. We are continuing to provide essential medical services throughout the COVID-19 crisis. Click here for information about COVID-19 and visiting UAB Medicine.
*UAB Medicine will continue seeing patients who need us most at our hospital and emergency departments. Clinic visits are available in person and also available through UAB eMedicine, which includes video and phone visits with a health care provider. To schedule a visit with a provider, please call the provider’s office directly or call 205-934-9999 or 800-822-8816.
*Your health and safety is our top priority. We are taking numerous steps to help prevent the spread of coronavirus, including special cleaning measures and practicing social distancing throughout our operations. Additionally, all patients, caregivers, and employees are required to wear a mask while in our facilities. Click here to learn more about safety measures.
*The UAB Medicine app is available for download from the app stores for both Apple iOS devices (iPhone/iPad) and Android devices. It gives patients easy access to many UAB Medicine services, including:
*The Patient Portal, where patients may request refills and send messages to providers.
*UAB eMedicine, which offers online diagnosis and treatment for common conditions.
*Online bill payment.
*Updates on the coronavirus and answers to common medical questions.
Read more news from UAB Medicine here.
*
Aug. 3 marked the official launch of GuideSafe™, a campus entry program for higher education.
*As of Aug. 17, 32 institutions across Alabama are participating in the GuideSafe™ re-entry program.
*The GuideSafe™ platform promotes safer entry methods through COVID-19 testing, tools, and actions. By using testing and self-reporting, the GuideSafe™ app provides ongoing COVID-19 monitoring, so institutions can make informed decisions and help stop the spread. The platform has three tools to help mitigate the risk of exposure and spread of COVID-19: Healthcheck, Exposure Notification Application, and Event Passport.
*The GuideSafe™ platform and set of tools were developed by a team of expert health, anthropology, and information technology leaders at UAB, part of the University of Alabama System. Supported by CARES Act funding, the GuideSafe™ Exposure Notification App was built by UAB and Birmingham-based MotionMobs, founded by UAB alumni, in active collaboration with the Alabama Department of Public Health.
*Click here to learn more about GuideSafe™, and check the news stories below for the latest news about our re-entry plans.And we led the way in our state’s response to the virus.
*We’ve advised key leaders across Alabama on best practices and next steps.
*We’ve partnered with and provided guidance to Governor Kay Ivey’s office, the Alabama Department of Public Health, Jefferson County Public Health, and regional hospitals.
*Selwyn Vickers, M.D., FACS, senior vice president for Medicine and dean of the School of Medicine, has played an important advisory role since the onset of the COVID-19 pandemic, serving on the Executive Committee of Governor Kay Ivey’s Coronavirus Task Force and as co-chair of The University of Alabama (UA) System Campus Health and Safety Initiative to develop reentry plans for the System’s three campuses in Tuscaloosa, Birmingham, and Huntsville.
*We’ve joined forces with the Provost’s Office, Health Services Foundation, UAB School of Public Health, and the UA System on operations, coordination, planning, and more. Our teams, units, and departments are committed to guiding the UAB enterprise on research, clinical care, testing, and clinical trials.Latest COVID-19 stories from across UABJoin a Clinical TrialUab Clinical Trials Cancer download free. full
Search active UAB clinical trials by age group, disease site and keywords.
Clinical trials are one way physicians and scientists actively participate in efforts to improve cancer therapies, diagnostic techniques and prevention strategies. Doctors at the O’Neal Comprehensive Cancer Center offer more than 200 cancer-related clinical trials exploring a wide array of therapies, diagnostics and preventive options, along with community-based trials in cancer survivorship research.
The Phase I Clinical Trials Program at the O’Neal Comprehensive Cancer Center is Alabama’s only close-to-home destination for novel cancer therapy options.
O’Neal Comprehensive Cancer Center members actively participate in cancer clinical trials through their own research protocols, as well as the high-priority trials and multicenter research collaborations through the Cancer Center’s membership in the National Cancer Institute’s National Clinical Trials Network. This multifaceted approach maintains the Center’s connections with the national cancer research community while fostering the development of translational research linked to UAB’s scientific resources.Frequently Asked QuestionsWhat are clinical trials?
Clinical trials are research studies in which patients can choose to participate. The O’Neal Comprehensive Cancer Center uses clinical trials to find new treatment options for patients and to develop new weapons in the fight against cancer.
A clinical trial is one of the final stages of a long and rigorous research process. The search for new treatments begins in the laboratory, where scientists first develop and test new ideas. If an approach seems promising, the next step may be testing a treatment in animals to see how it affects cancer in a living being.
Clinical trials are conducted in phases to study different aspects of treatments in individuals. Therapies which are the result of successful clinical trials often become standard-of-care treatments for people with cancer.What is the difference between Phase I, Phase II and Phase III clinical trials?
Each phase answers different questions about the new treatment.
Phase I trials are the first step in testing a new treatment in humans. In these studies, physicians and scientists aim to find a safe dose, decide how the new treatment should be given and see how the new treatment affects the human body and fights cancer.
Phase II trials focus on learning if the new treatment has an effect on a certain cancer and how the new treatment affects the body and fights cancer.
Phase III trials compare the new treatment (or new use of treatment) with the current standard-of-care treatment. In most cases, studies move into Phase III testing only after a treatment shows promise in Phases I and II trials. Phase III trials may include hundreds of people around the country.
Why are clinical trials important?
Clinical trials give doctors and patients new tools in the fight against cancer. Clinical trials contribute to knowledge and progress against cancer. If a new treatment proves effective in a study, it may become a new standard treatment that can help many patients. Many of today’s most effective standard treatments are based on previous study results. Clinical trials may also answer important scientific questions and suggest future directions in cancer research.
Just as important, patients who volunteer for clinical trials may be personally helped by the treatment they receive throughout the course of the trial. They get up-to-date care from cancer experts, and they receive either a new treatment being tested or the best available standard treatment for their cancer.
While there is no guarantee that a new treatment being tested or a standard treatment will produce good results, if a new treatment proves effective or more effective than standard treatment, study patients who receive it may be among the first to benefit. Some patients receive only standard treatment and benefit from it.What care should I expect while participating in a clinical trial?
When you take part in a clinical trial, you receive your treatment in a cancer center, hospital, clinic and/or doctor’s office. Doctors, nurses, social workers and other health care providers may be part of your care team. They will follow your progress closely. You may have more tests and doctor visits than you would if you were not taking part in a study.
You will follow a treatment plan prescribed by your doctor, and you may have other responsibilities such as keeping a log or filling out forms about your health. Some studies continue to check on patients even after their treatment is over.Should I enroll in a clinical trial?
Deciding whether or not to enroll in a clinical trial is a question only you, your loved ones and your care team can answer together. Learning you have cancer and deciding what to do about it is often overwhelming, so talking with those closet to you and your treatment plan can help you understand the all aspects of participating in a clinical trial, including the benefits and drawbacks, your protections as a patient and any financial and/or insurance considerations.What questions should I ask my doctor about participating in a clinical trial?
Finding answers and making choices may be hard for people with cancer and those who care about them. It is important to discuss your treatment choices with your doctor, your oncologist and the staff of any clinical trial you consider entering.
Ask questions about the information you receive during the informed consent process and about any other issues that concern you. Getting answers can help you work better with the doctor. You may want to take a friend or relative along when you talk to the doctor. It also may help to write down your questions and the answers you receive, or bring a tape recorder to record what is said. No question about your care is foolish. It is very important to understand your choices.Here are some questions you may want to ask:
About the study:
*What is the purpose of the study? In what phase is this study?
*Why do researchers believe the new treatment being tested may be effective? Has it been tested before?
*Who sponsors the study, and who has reviewed and approved it?
*How are the study data and patient safety being checked?
*When and where will study results and information go? Possible Risks and Benefits
*What are the possible short- and long-term risks, side effects, and benefits to me?
*Are there standard treatments for my type of cancer?
*How do the possible risks, side effects, and benefits in the study compare with standard treatment?Uab Clinical Trials Cancer Download Free Version
About your care:
*Where will my treatment take place? Will I have to be in the hospital? If so, how often and for how long?
*How will I know if the treatment is working?
*Will I be able to see my own doctor? Who will be in charge of my care?
About your life: Games for mac.
*How could the study affect my daily life?
*Can you put me in touch with other people who are in this study?
*What support is there for me and my family in the community?
About the cost:
*Will I have to pay for any treatment, tests, or other charges?
*What is my health insurance likely to cover?
*Who can help answer any questions from my insurance company or managed care plan?
For questions regarding cancer, you may contact Cancer Answers and speak with an Oncology Nurse, 1-800-UAB-0933.
Download here: http://gg.gg/ukh8i
https://diarynote.indered.space
*Uab Clinical Trials Cancer download free. full
*Uab Clinical Trials Cancer Download Free Version
*UAB Medicine is changing the world of healthcare. As a leading academic medical center and Alabama’s largest employer, UAB is a national leader in patient care, research, and training. Medical professionals from around the nation look to us to be in the vanguard of medicine, and we deliver on that expectation. email protected.
*The motto of the UAB Phase 1 Clinical Trials Program is ’ ”. It is dedicated to provide HOPE to cancer patients options and compassionate care. It is our hope that patients with cancer, for whom conventional therapeutic options no longer provide benefits, will come to see the Phase 1.
*There are now four single-institution published randomized trials comparing LDR to HDR brachytherapy,. Our objective of this report is to evaluate clinical outcome of cervical cancer patients treated at the University of Alabama at Birmingham (UAB) with either LDR or HDR brachytherapy within the same period of time.We responded agressively to COVID-19 when it struck.
UAB Department of Genetics Clinical Programs Prenatal Pediatric Adult Cancer Specialty Clinics Clinical Lab Cytogenetics Medical Genomics Biochemical Genetics Research Cancer Genetics Systems Biology Bioinformatics Animal Models Clinical Trials Developmental Biology Core Labs Transgenic/Animal Models Genomics Education Graduate Undergraduate.We’re making an impact on the COVID-19 crisis through research, testing, guidance, and community care. Our leadership and infectious disease experts have been working around the clock to ensure the most effective plans are executed to guide our enterprise, the Birmingham community, and the State of Alabama. Our mission is to partner with stakeholders and influencers to ensure the health and safety of all Alabamians.We went to work in all areas of our mission.
*
UAB is committed to decreasing racial and socioeconomic disparities for health and health care. The COVID-19 pandemic has exposed the deadly consequences of health disparities, and our leaders recognize the importance of informing the public about health disparities and developing effective strategies to combat them.
*Community-based COVID-19 testing sites in underserved areas launched April 30. The sites employ a mobile, drive-through, and walk-up testing model, and are currently serving many minority communities who may have transportation or health care barriers. Testing has been offered at locations across Jefferson County. Culturally-sensitive Patient Navigators guide individuals through pre-screening, testing, and test results.
*Mobile community testing is possible due to UAB’s partnerships with the Jefferson County Department of Health, UAB Medicine, Live HealthSmart Alabama, and the Minority Health & Health Disparities Research Center.
*COVID-19 education is being disseminated at each site, and across Jefferson County to help stop the spread of the virus.
*
UAB clinicians and researchers work around the clock to make testing available for as many people as possible.
*Sentinel testing is voluntary for staff and faculty, and individuals are selected at random to participate. Multiple other options for testing are available to UAB employees.
*All students on campus are required to get tested. Read more here.
*The GuideSafe™ Exposure Notification App tracks symptoms of individuals and directs them to a testing site based on their employment and/or student status.
*
UAB continues to be a leader in fighting the COVID-19 crisis with clinical trials and research.
*On May 1, 14 basic science projects were selected for funding due to their high-impact probability on COVID-19. Read more here.
*On Aug. 1, a second round of research initiatives began, focusing on high-impact studies related to COVID-19—from vaccines and therapeutics to antibodies, disparity risk, cytokine syndrome, and much more. Out of the 10 pilot projects, all principal investigators or co-investigators were selected from the School of Medicine, and one investigator was selected from the School of Public Health in the Department of Epidemiology.
*UAB is a participant in the NIH-sponsored global clinical trial to evaluate the safety and efficacy of the novel therapeutic drug, remdesivir. UAB is also conducting a first-in-U.S. study that is testing a treatment to halt the potentially fatal immune overreaction known as cytokine storm syndrome in COVID-19 patients. Last, expanded access protocol for use of COVID-19 convalescent plasma was activated onsite at UAB in spring 2020 organized through the NIH/NCATS’s Trial Innovation Network.
*Browse research articles related to COVID-19 from UAB News.
*
As the 2020-2021 academic year began, the School of Medicine found ways to continue to meet our mission of training the next generation of leaders in medicine while safeguarding the health and safety of our students and trainees. Under the direction of Craig Hoesley, M.D., senior associate dean for Medical Education, program leaders continue to follow guidance shared by the AAMC and communicate regularly with each class to ensure they have the latest information possible.
Medical students looking for updates can visit the COVID-19 Updates and FAQs page on the School of Medicine website.
*Many preclinical courses moved to virtual learning, while clinical coursework continues with enhanced health check protocols to ensure the safety of our students and the patients they encounter.
*Medical students have found numerous ways to contribute their time and service to those in need during the pandemic. Many have volunteered for organizations that are providing a variety of services to the community, including Bham Strong, Christ Health Center, and the UAB COVID-19 call center, among others. Read more about their contributions from SOM News.
*While annual events like Match Day, Commencement, and the White Coat Welcome celebration were modified and moved to an online format, care was taken to ensure that these milestone events were still meaningful and memorable for our students. (A full White Coat Ceremony will be held for the 2020 entering class at the beginning of their third year of medical school.)
*Read more about how the School of Medicine’s medical education programs are reacting and adapting to the challenges of the COVID-19 pandemic in the news stories below.
*
We are honored that millions of patients each year trust UAB Medicine with their care. We are continuing to provide essential medical services throughout the COVID-19 crisis. Click here for information about COVID-19 and visiting UAB Medicine.
*UAB Medicine will continue seeing patients who need us most at our hospital and emergency departments. Clinic visits are available in person and also available through UAB eMedicine, which includes video and phone visits with a health care provider. To schedule a visit with a provider, please call the provider’s office directly or call 205-934-9999 or 800-822-8816.
*Your health and safety is our top priority. We are taking numerous steps to help prevent the spread of coronavirus, including special cleaning measures and practicing social distancing throughout our operations. Additionally, all patients, caregivers, and employees are required to wear a mask while in our facilities. Click here to learn more about safety measures.
*The UAB Medicine app is available for download from the app stores for both Apple iOS devices (iPhone/iPad) and Android devices. It gives patients easy access to many UAB Medicine services, including:
*The Patient Portal, where patients may request refills and send messages to providers.
*UAB eMedicine, which offers online diagnosis and treatment for common conditions.
*Online bill payment.
*Updates on the coronavirus and answers to common medical questions.
Read more news from UAB Medicine here.
*
Aug. 3 marked the official launch of GuideSafe™, a campus entry program for higher education.
*As of Aug. 17, 32 institutions across Alabama are participating in the GuideSafe™ re-entry program.
*The GuideSafe™ platform promotes safer entry methods through COVID-19 testing, tools, and actions. By using testing and self-reporting, the GuideSafe™ app provides ongoing COVID-19 monitoring, so institutions can make informed decisions and help stop the spread. The platform has three tools to help mitigate the risk of exposure and spread of COVID-19: Healthcheck, Exposure Notification Application, and Event Passport.
*The GuideSafe™ platform and set of tools were developed by a team of expert health, anthropology, and information technology leaders at UAB, part of the University of Alabama System. Supported by CARES Act funding, the GuideSafe™ Exposure Notification App was built by UAB and Birmingham-based MotionMobs, founded by UAB alumni, in active collaboration with the Alabama Department of Public Health.
*Click here to learn more about GuideSafe™, and check the news stories below for the latest news about our re-entry plans.And we led the way in our state’s response to the virus.
*We’ve advised key leaders across Alabama on best practices and next steps.
*We’ve partnered with and provided guidance to Governor Kay Ivey’s office, the Alabama Department of Public Health, Jefferson County Public Health, and regional hospitals.
*Selwyn Vickers, M.D., FACS, senior vice president for Medicine and dean of the School of Medicine, has played an important advisory role since the onset of the COVID-19 pandemic, serving on the Executive Committee of Governor Kay Ivey’s Coronavirus Task Force and as co-chair of The University of Alabama (UA) System Campus Health and Safety Initiative to develop reentry plans for the System’s three campuses in Tuscaloosa, Birmingham, and Huntsville.
*We’ve joined forces with the Provost’s Office, Health Services Foundation, UAB School of Public Health, and the UA System on operations, coordination, planning, and more. Our teams, units, and departments are committed to guiding the UAB enterprise on research, clinical care, testing, and clinical trials.Latest COVID-19 stories from across UABJoin a Clinical TrialUab Clinical Trials Cancer download free. full
Search active UAB clinical trials by age group, disease site and keywords.
Clinical trials are one way physicians and scientists actively participate in efforts to improve cancer therapies, diagnostic techniques and prevention strategies. Doctors at the O’Neal Comprehensive Cancer Center offer more than 200 cancer-related clinical trials exploring a wide array of therapies, diagnostics and preventive options, along with community-based trials in cancer survivorship research.
The Phase I Clinical Trials Program at the O’Neal Comprehensive Cancer Center is Alabama’s only close-to-home destination for novel cancer therapy options.
O’Neal Comprehensive Cancer Center members actively participate in cancer clinical trials through their own research protocols, as well as the high-priority trials and multicenter research collaborations through the Cancer Center’s membership in the National Cancer Institute’s National Clinical Trials Network. This multifaceted approach maintains the Center’s connections with the national cancer research community while fostering the development of translational research linked to UAB’s scientific resources.Frequently Asked QuestionsWhat are clinical trials?
Clinical trials are research studies in which patients can choose to participate. The O’Neal Comprehensive Cancer Center uses clinical trials to find new treatment options for patients and to develop new weapons in the fight against cancer.
A clinical trial is one of the final stages of a long and rigorous research process. The search for new treatments begins in the laboratory, where scientists first develop and test new ideas. If an approach seems promising, the next step may be testing a treatment in animals to see how it affects cancer in a living being.
Clinical trials are conducted in phases to study different aspects of treatments in individuals. Therapies which are the result of successful clinical trials often become standard-of-care treatments for people with cancer.What is the difference between Phase I, Phase II and Phase III clinical trials?
Each phase answers different questions about the new treatment.
Phase I trials are the first step in testing a new treatment in humans. In these studies, physicians and scientists aim to find a safe dose, decide how the new treatment should be given and see how the new treatment affects the human body and fights cancer.
Phase II trials focus on learning if the new treatment has an effect on a certain cancer and how the new treatment affects the body and fights cancer.
Phase III trials compare the new treatment (or new use of treatment) with the current standard-of-care treatment. In most cases, studies move into Phase III testing only after a treatment shows promise in Phases I and II trials. Phase III trials may include hundreds of people around the country.
Why are clinical trials important?
Clinical trials give doctors and patients new tools in the fight against cancer. Clinical trials contribute to knowledge and progress against cancer. If a new treatment proves effective in a study, it may become a new standard treatment that can help many patients. Many of today’s most effective standard treatments are based on previous study results. Clinical trials may also answer important scientific questions and suggest future directions in cancer research.
Just as important, patients who volunteer for clinical trials may be personally helped by the treatment they receive throughout the course of the trial. They get up-to-date care from cancer experts, and they receive either a new treatment being tested or the best available standard treatment for their cancer.
While there is no guarantee that a new treatment being tested or a standard treatment will produce good results, if a new treatment proves effective or more effective than standard treatment, study patients who receive it may be among the first to benefit. Some patients receive only standard treatment and benefit from it.What care should I expect while participating in a clinical trial?
When you take part in a clinical trial, you receive your treatment in a cancer center, hospital, clinic and/or doctor’s office. Doctors, nurses, social workers and other health care providers may be part of your care team. They will follow your progress closely. You may have more tests and doctor visits than you would if you were not taking part in a study.
You will follow a treatment plan prescribed by your doctor, and you may have other responsibilities such as keeping a log or filling out forms about your health. Some studies continue to check on patients even after their treatment is over.Should I enroll in a clinical trial?
Deciding whether or not to enroll in a clinical trial is a question only you, your loved ones and your care team can answer together. Learning you have cancer and deciding what to do about it is often overwhelming, so talking with those closet to you and your treatment plan can help you understand the all aspects of participating in a clinical trial, including the benefits and drawbacks, your protections as a patient and any financial and/or insurance considerations.What questions should I ask my doctor about participating in a clinical trial?
Finding answers and making choices may be hard for people with cancer and those who care about them. It is important to discuss your treatment choices with your doctor, your oncologist and the staff of any clinical trial you consider entering.
Ask questions about the information you receive during the informed consent process and about any other issues that concern you. Getting answers can help you work better with the doctor. You may want to take a friend or relative along when you talk to the doctor. It also may help to write down your questions and the answers you receive, or bring a tape recorder to record what is said. No question about your care is foolish. It is very important to understand your choices.Here are some questions you may want to ask:
About the study:
*What is the purpose of the study? In what phase is this study?
*Why do researchers believe the new treatment being tested may be effective? Has it been tested before?
*Who sponsors the study, and who has reviewed and approved it?
*How are the study data and patient safety being checked?
*When and where will study results and information go? Possible Risks and Benefits
*What are the possible short- and long-term risks, side effects, and benefits to me?
*Are there standard treatments for my type of cancer?
*How do the possible risks, side effects, and benefits in the study compare with standard treatment?Uab Clinical Trials Cancer Download Free Version
About your care:
*Where will my treatment take place? Will I have to be in the hospital? If so, how often and for how long?
*How will I know if the treatment is working?
*Will I be able to see my own doctor? Who will be in charge of my care?
About your life: Games for mac.
*How could the study affect my daily life?
*Can you put me in touch with other people who are in this study?
*What support is there for me and my family in the community?
About the cost:
*Will I have to pay for any treatment, tests, or other charges?
*What is my health insurance likely to cover?
*Who can help answer any questions from my insurance company or managed care plan?
For questions regarding cancer, you may contact Cancer Answers and speak with an Oncology Nurse, 1-800-UAB-0933.
Download here: http://gg.gg/ukh8i
https://diarynote.indered.space
コメント